Source: Annual Congress 2004 - Targeting acute and chronic airway obstruction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. H. Boskabady, H. H. Farhadi (Mashhad, Iran). Airway responsiveness to beta-adrenergic agonist in smokers. Eur Respir J 2004; 24: Suppl. 48, 2147

Member's Comments

No comment yet.

Related content which might interest you: Increased airway responsiveness to beta-adrenergic agonists in asthmatic patients Source: Eur Respir J 2005; 26: Suppl. 49, 582s Year: 2005 Airway responsiveness and reversibility of bronchconstriction in smokers Source: Eur Respir J 2006; 28: Suppl. 50, 219s Year: 2006 Effect of an inhaled adenosine A2A agonist on the allergen induced late asthmatic response Source: Eur Respir J 2003; 22: Suppl. 45, 204s Year: 2003 Effect of AVE5883, a dual NK1/NK2 receptor antagonist, on airway responsiveness to neurokinin A in asthma Source: Eur Respir J 2004; 24: Suppl. 48, 219s Year: 2004 Paradoxical bronchoconstriction after administration of beta-2 agonist bronchodilators in COPD patients Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Cholinergic muscarinic receptors and airway remodelling in severe asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Mice lacking both M2 and M3 muscarinic receptors display airway hyperresponsiveness (AHR) to serotonin Source: Eur Respir J 2005; 26: Suppl. 49, 714s Year: 2005 Anti-inflammatory effects of histamine H1-receptor antagonist and leukotriene CysLT1-receptor antagonist in patients with atopic asthma maintained on inhaled corticosteroids Source: Eur Respir J 2004; 24: Suppl. 48, 221s Year: 2004 The CysLT1 receptor antagonist montelukast blocks bronchoconstriction induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Potentiation effect of insulin on M3 muscarinic receptor agonist induced airway smooth muscle contraction Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 Tracheal responsiveness to histamine and H1 receptor blockade in cigarette smoke exposed and sensitized animals Source: Eur Respir J 2005; 26: Suppl. 49, 581s Year: 2005 Antigen-induced airway hyperresponsiveness and eosinophilia in mice is inhibited by the endothelin receptor antagonist SB217242 Source: Eur Respir J 2001; 18: Suppl. 33, 349s Year: 2001 Effect of inhaled beta2 agonist on lung compliance in patients with COPD with poor bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006 Analysis of spirometric responsiveness to beta2 agonist in the diagnosis of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 223s Year: 2004 Tracheal responsiveness to isoprenaline and beta2-adrenoreceptor blockade by propranolol in cigarette smoke exposed and sensitized guinea pigs Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008 Beta 2-adrenergic receptor polymorphisms and bronchial hyperresponsiveness in asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 616s Year: 2005 Inhibition of the inhaled allergen challenge response by the CRTH2 antagonist OC000459 in patients with asthma Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 Effects of leukotriene receptor antagonists on airway mucus secretion Source: Eur Respir J 2001; 18: Suppl. 33, 245s Year: 2001 In vivo potent and long-lasting bronchodilator activity of muscarinic M3 receptor antagonist CHF5407 Source: Eur Respir J 2007; 30: Suppl. 51, 26s Year: 2007 Characterising the cardiovascular safety profile of inhaled muscarinic receptor antagonists Source: Eur Respir Monogr 2020; 88: 238-250 Year: 2020